Table Of Contents

1. Introduction 19
1.1. Objectives Of The Study 19
1.2. Market Definition 19
1.3. Overview Of Asia-Pacific Exoskeleton Market 19
1.4. Currency And Pricing 20
1.5. Limitation 20
1.6. Markets Covered 21
2. Market Segmentation 23
2.1. Markets Covered 23
2.2. Geographic Scope 24
2.3. Years Considered For The Study 25
2.4. Currency And Pricing 25
2.5. Research Methodology 26
2.6. Primary Interviews With Key Opinion Leaders 29
2.7. Secondary Sources 30
2.8. Assumptions 30
3. Market Overview 31
3.1. Drivers 33
3.1.1. Growing Geriatric Population 33
3.1.2. Advent Of Robotic Technologies 34
3.1.3. Increased Investment Towards Exoskeleton Technology 35
3.2. Restraints 36
3.2.1. High Equipment Cost 36
3.3. Opportunity 37
3.3.1. Increasing Fda Approval And Clearance 37
3.3.2. Rising Acceptance Of Human Augmentation In Industrial And Military Sectors 37
3.4. Challenges 38
3.4.1. Issue Involved In Reimbursement Policies 38
4. Executive Summary 39
5. Premium Insights 41
6. Asia-Pacific Exoskeleton Market, By Component 44
6.1. Overview 45
6.2. Hardware 48
6.2.1. Sensors 49
6.2.1.1. Accelerometer 49
6.2.1.2. Gyroscope 49
6.2.1.3. Tilt Sensor 49
6.2.1.4. Microphones 49
6.2.1.5. Position Sensors 50
6.2.1.6. Force Sensors 50
6.2.1.7. Others 50
6.2.2. Power Source 51
6.2.3. Actuator 51
6.2.3.1. Electrical 51
6.2.3.2. Piezoelectric 51
6.2.3.3. Pneumatic 52
6.2.3.4. Hydraulic 52
6.2.3.5. Others 52
6.2.4. Control System/ Controller 53
6.2.5. Others 53
6.3. Software 54
?
7. Asia-Pacific Exoskeleton Market, By Mobility 55
7.1. Overview 56
7.2. Stationary 58
7.3. Mobile 59
8. Asia-Pacific Exoskeleton Market, By Type 60
8.1. Overview 61
8.2. Powered 63
8.3. Passive 64
9. Asia-Pacific Exoskeleton Market, By Body Parts 65
9.1. Overview 66
9.2. Upper Extremities 68
9.3. Lower Extremities 69
9.4. Full Body 70
10. Asia-Pacific Exoskeleton Market, By End User 71
10.1. Overview 72
10.2. Healthcare 74
10.2.1. Rehabilitation 75
10.2.2. Elderly Care 75
10.3. Defense/Military 76
10.4. Industrial 77
11. Asia-Pacific Exoskeleton Market By Geography 78
11.1. Asia-Pacific 78
11.1.1. Japan 90
11.1.2. China 95
11.1.3. India 99
11.1.4. South Korea 103
11.1.5. Australia 108
11.1.6. Singapore 112
11.1.7. Thailand 117
11.1.8. Malaysia 121
11.1.9. Indonesia 125
11.1.10. Philippines 130
11.1.11. Rest Of Asia-Pacific 135
12. Asia-Pacific Exoskeleton Market, Company Landscape 136
12.1. Company Share Analysis; Asia Pacific 136
13. Company Profiles 137
13.1. Atoun Inc. 137
13.1.1. Company Overview 137
13.1.2. Atoun Inc. ; Company Snapshot 137
13.1.3. Product Portfolio 138
13.1.4. Recent Developments 138
13.2. Suit X 139
13.2.1. Company Overview 139
13.2.2. Suitx; Company Snapshot 139
13.2.3. Product Portfolio 140
13.2.4. Recent Developments 140
13.3. Hocoma 141
13.3.1. Company Overview 141
13.3.2. Hocoma; Company Snapshot 141
13.3.3. Product Portfolio 142
13.3.4. Recent Developments 142
13.4. Rex Bionics Ltd 143
13.4.1. Company Overview 143
13.4.2. Rex Bionics Ltd; Company Snapshot 143
13.4.3. Product Portfolio 144
13.4.4. Recent Developments 144
13.5. Rewalk Robotics 145
13.5.1. Company Overview 145
13.5.2. Rewalk Robotics; Revenue Analysis 145
13.5.3. Product Portfolio 146
13.5.4. Recent Developments 146
13.6. Rb3D 147
13.6.1. Company Overview 147
13.6.2. Rb3D; Company Snapshot 147
13.6.3. Product Portfolio 148
13.6.4. Recent Developments 148
13.7. Raytheon Company 149
13.7.1. Company Overview 149
13.7.2. Raytheon Company ; Revenue Analysis 149
13.7.3. Product Portfolio 150
13.7.4. Recent Developments 150
13.8. Parker Hannifin Corp 151
13.8.1. Company Overview 151
13.8.2. Parker Hannifin Corp; Revenue Analysis 151
13.8.3. Product Portfolio 152
13.8.4. Recent Developments 152
13.9. Ottobock 153
13.9.1. Company Overview 153
13.9.2. Ottobock; Company Snapshot 153
13.9.3. Product Portfolio 154
13.9.4. Recent Developments 154
13.10. Fourier Intelligence Co., Ltd. 155
13.10.1. Company Overview 155
13.10.2. Fourier Intelligence Co., Ltd.; Company Snapshot 155
13.10.3. Product Portfolio 156
13.10.4. Recent Developments 156
13.11. Esco Bionics 157
13.11.1. Company Overview 157
13.11.2. Esco Bionics ; Revenue Analysis 157
13.11.3. Product Portfolio 158
13.11.4. Recent Developments 158
13.12. B-Temia 159
13.12.1. Company Overview 159
13.12.2. B-Temia ;Company Snapshot 159
13.12.3. Product Portfolio 160
13.12.4. Recent Developments 160
13.13. Focal Meditech Bv 161
13.13.1. Company Overview 161
13.13.2. Focal Meditech Bv ; Company Snapshot 161
13.13.3. Product Portfolio 162
13.13.4. Recent Developments 163
13.14. Cyberdyne, Inc. 164
13.14.1. Company Overview 164
13.14.2. Cyberdyne,Inc. ; Revenue Analysis 164
13.14.3. Product Portfolio 165
13.14.4. Recent Developments 165
13.15. Bionik Laboratories Corp. 166
13.15.1. Company Overview 166
13.15.2. Bionik Laboratories Corp. ; Revenue Analysis 166
13.15.3. Product Portfolio 167
13.15.4. Recent Developments 167
?
13.16. Lockheed Martin Corporation 168
13.16.1. Company Overview 168
13.16.2. Lockheed Martin Corporation; Revenue Analysis 168
13.16.3. Product Portfolio 169
13.16.4. Recent Developments 170
13.17. Dih Technologies Corporation 171
13.17.1. Company Overview 171
13.17.2. Dih Technologies Corporation; Company Snapshot 171
13.17.3. Product Portfolio 172
13.17.4. Recent Developments 172
13.18. Gogoa 173
13.18.1. Company Overview 173
13.18.2. Gogoa; Revenue Analysis 173
13.18.3. Product Portfolio 174
13.18.4. Recent Developments 174
13.19. Honda Motor Co., Ltd. 175
13.19.1. Company Overview 175
13.19.2. Honda Motor Co., Ltd.; Revenue Analysis 175
13.19.3. Product Portfolio 176
13.19.4. Recent Developments 176
13.20. Exhauss 177
13.20.1. Company Overview 177
13.20.2. Exhauss; Company Snapshot 177
13.20.3. Product Portfolio 178
13.20.4. Recent Developments 178
14. Related Reports 179